HEADER TRANSCRIPTION 24-DEC-22 8HUK TITLE X-RAY STRUCTURE OF HUMAN PPAR ALPHA LIGAND BINDING DOMAIN- TITLE 2 LANIFIBRANOR-SRC1 COACTIVATOR PEPTIDE CO-CRYSTALS OBTAINED BY SOAKING COMPND MOL_ID: 1; COMPND 2 MOLECULE: PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR ALPHA; COMPND 3 CHAIN: A, C; COMPND 4 ENGINEERED: YES; COMPND 5 MOL_ID: 2; COMPND 6 MOLECULE: 15-MERIC PEPTIDE FROM NUCLEAR RECEPTOR COACTIVATOR 1; COMPND 7 CHAIN: B; COMPND 8 EC: 2.3.1.48; COMPND 9 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 7 MOL_ID: 2; SOURCE 8 SYNTHETIC: YES; SOURCE 9 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 10 ORGANISM_COMMON: HUMAN; SOURCE 11 ORGANISM_TAXID: 9606 KEYWDS NUCLEAR RECEPTOR, PROTEIN-LIGAND COMPLEX, PPAR, TRANSCRIPTION EXPDTA X-RAY DIFFRACTION AUTHOR S.KAMATA,R.ISHIKAWA,M.AKAHANE,A.HONDA,T.OYAMA,I.ISHII REVDAT 2 06-SEP-23 8HUK 1 JRNL REVDAT 1 09-AUG-23 8HUK 0 JRNL AUTH S.KAMATA,A.HONDA,R.ISHIKAWA,M.AKAHANE,A.FUJITA,C.KANEKO, JRNL AUTH 2 S.MIYAWAKI,Y.HABU,Y.SHIIYAMA,K.UCHII,Y.MACHIDA,T.OYAMA, JRNL AUTH 3 I.ISHII JRNL TITL FUNCTIONAL AND STRUCTURAL INSIGHTS INTO THE HUMAN PPAR ALPHA JRNL TITL 2 / DELTA / GAMMA TARGETING PREFERENCES OF ANTI-NASH JRNL TITL 3 INVESTIGATIONAL DRUGS, LANIFIBRANOR, SELADELPAR, AND JRNL TITL 4 ELAFIBRANOR. JRNL REF ANTIOXIDANTS V. 12 2023 JRNL REFN ESSN 2076-3921 JRNL PMID 37627519 JRNL DOI 10.3390/ANTIOX12081523 REMARK 2 REMARK 2 RESOLUTION. 2.98 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.11.1-2575-000 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.98 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 39.20 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.870 REMARK 3 COMPLETENESS FOR RANGE (%) : 94.3 REMARK 3 NUMBER OF REFLECTIONS : 14434 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.201 REMARK 3 R VALUE (WORKING SET) : 0.197 REMARK 3 FREE R VALUE : 0.254 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.570 REMARK 3 FREE R VALUE TEST SET COUNT : 1501 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 39.2020 - 6.6204 0.98 2394 130 0.1572 0.1764 REMARK 3 2 6.6204 - 5.2588 0.92 2295 111 0.2326 0.2605 REMARK 3 3 5.2588 - 4.5952 0.95 2316 126 0.1787 0.2160 REMARK 3 4 4.5952 - 4.1756 0.96 2383 146 0.1814 0.3026 REMARK 3 5 4.1756 - 3.8766 0.96 2356 148 0.1890 0.2741 REMARK 3 6 3.8766 - 3.6482 0.96 2335 139 0.1950 0.2206 REMARK 3 7 3.6482 - 3.4656 0.96 2352 127 0.2209 0.3050 REMARK 3 8 3.4656 - 3.3149 0.96 2336 166 0.2247 0.2646 REMARK 3 9 3.3149 - 3.1873 0.95 2320 135 0.2466 0.3335 REMARK 3 10 3.1873 - 3.0774 0.94 2345 123 0.2991 0.4316 REMARK 3 11 3.0774 - 2.9812 0.84 2019 150 0.3347 0.4364 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.400 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 34.450 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 81.21 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 100.2 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.002 4299 REMARK 3 ANGLE : 0.405 5799 REMARK 3 CHIRALITY : 0.033 665 REMARK 3 PLANARITY : 0.002 735 REMARK 3 DIHEDRAL : 11.907 2623 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 8HUK COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 05-JAN-23. REMARK 100 THE DEPOSITION ID IS D_1300031703. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 08-MAR-20 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : PHOTON FACTORY REMARK 200 BEAMLINE : BL-17A REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.00000 REMARK 200 MONOCHROMATOR : SI(111) REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS EIGER X 16M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS 0.5.21 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 14504 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.980 REMARK 200 RESOLUTION RANGE LOW (A) : 45.480 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.3 REMARK 200 DATA REDUNDANCY : 3.400 REMARK 200 R MERGE (I) : 0.05000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 12.3000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.98 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.16 REMARK 200 COMPLETENESS FOR SHELL (%) : 98.8 REMARK 200 DATA REDUNDANCY IN SHELL : 3.10 REMARK 200 R MERGE FOR SHELL (I) : 0.31500 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 34.10 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER 2.7.16 REMARK 200 STARTING MODEL: 3SP6 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 56.75 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.84 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1 M TRIS (PH 8.5), 25%(W/V) PEG3350, REMARK 280 VAPOR DIFFUSION, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 50.69150 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1080 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 13680 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -9.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 0 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 13080 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: 0.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 196 REMARK 465 SER A 197 REMARK 465 HIS A 198 REMARK 465 MET A 199 REMARK 465 ALA A 256 REMARK 465 LYS A 257 REMARK 465 LEU A 258 REMARK 465 VAL A 259 REMARK 465 ALA A 260 REMARK 465 ASN A 261 REMARK 465 GLY A 262 REMARK 465 ILE A 263 REMARK 465 GLN A 264 REMARK 465 ASN A 265 REMARK 465 LEU B 683 REMARK 465 THR B 684 REMARK 465 GLU B 685 REMARK 465 ARG B 686 REMARK 465 GLY B 697 REMARK 465 GLY C 196 REMARK 465 SER C 197 REMARK 465 HIS C 198 REMARK 465 MET C 199 REMARK 465 VAL C 255 REMARK 465 ALA C 256 REMARK 465 LYS C 257 REMARK 465 LEU C 258 REMARK 465 VAL C 259 REMARK 465 ALA C 260 REMARK 465 ASN C 261 REMARK 465 GLY C 262 REMARK 465 ILE C 263 REMARK 465 GLN C 264 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 232 CG CD CE NZ REMARK 470 HIS B 691 CG ND1 CD2 CE1 NE2 REMARK 470 LYS C 232 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 221 -168.30 -113.07 REMARK 500 LYS A 232 136.31 66.75 REMARK 500 ALA A 233 19.65 53.82 REMARK 500 SER A 234 -61.44 -138.43 REMARK 500 ASN A 235 -32.36 71.59 REMARK 500 PRO A 295 103.31 -58.87 REMARK 500 LEU A 347 158.76 -43.91 REMARK 500 LEU A 392 -85.69 -71.85 REMARK 500 ASN A 393 69.52 -69.88 REMARK 500 ARG A 465 100.86 -53.01 REMARK 500 MET A 467 -87.37 -69.77 REMARK 500 LYS B 688 -42.19 -149.80 REMARK 500 ILE B 689 -172.04 -69.19 REMARK 500 LEU B 690 -73.98 64.78 REMARK 500 LYS C 216 34.98 -94.04 REMARK 500 ASN C 217 -27.52 -155.43 REMARK 500 SER C 230 -118.24 -127.95 REMARK 500 LYS C 232 16.56 52.68 REMARK 500 ALA C 233 119.05 150.11 REMARK 500 SER C 234 39.81 -162.27 REMARK 500 ASN C 235 -0.51 69.30 REMARK 500 LEU C 392 -71.38 -85.82 REMARK 500 ASP C 419 78.94 -118.99 REMARK 500 ALA C 454 70.47 -104.80 REMARK 500 MET C 467 -89.07 -83.10 REMARK 500 REMARK 500 REMARK: NULL DBREF 8HUK A 200 468 UNP Q07869 PPARA_HUMAN 200 468 DBREF 8HUK B 683 697 UNP Q15788 NCOA1_HUMAN 683 697 DBREF 8HUK C 200 468 UNP Q07869 PPARA_HUMAN 200 468 SEQADV 8HUK GLY A 196 UNP Q07869 EXPRESSION TAG SEQADV 8HUK SER A 197 UNP Q07869 EXPRESSION TAG SEQADV 8HUK HIS A 198 UNP Q07869 EXPRESSION TAG SEQADV 8HUK MET A 199 UNP Q07869 EXPRESSION TAG SEQADV 8HUK GLY C 196 UNP Q07869 EXPRESSION TAG SEQADV 8HUK SER C 197 UNP Q07869 EXPRESSION TAG SEQADV 8HUK HIS C 198 UNP Q07869 EXPRESSION TAG SEQADV 8HUK MET C 199 UNP Q07869 EXPRESSION TAG SEQRES 1 A 273 GLY SER HIS MET THR ALA ASP LEU LYS SER LEU ALA LYS SEQRES 2 A 273 ARG ILE TYR GLU ALA TYR LEU LYS ASN PHE ASN MET ASN SEQRES 3 A 273 LYS VAL LYS ALA ARG VAL ILE LEU SER GLY LYS ALA SER SEQRES 4 A 273 ASN ASN PRO PRO PHE VAL ILE HIS ASP MET GLU THR LEU SEQRES 5 A 273 CYS MET ALA GLU LYS THR LEU VAL ALA LYS LEU VAL ALA SEQRES 6 A 273 ASN GLY ILE GLN ASN LYS GLU ALA GLU VAL ARG ILE PHE SEQRES 7 A 273 HIS CYS CYS GLN CYS THR SER VAL GLU THR VAL THR GLU SEQRES 8 A 273 LEU THR GLU PHE ALA LYS ALA ILE PRO GLY PHE ALA ASN SEQRES 9 A 273 LEU ASP LEU ASN ASP GLN VAL THR LEU LEU LYS TYR GLY SEQRES 10 A 273 VAL TYR GLU ALA ILE PHE ALA MET LEU SER SER VAL MET SEQRES 11 A 273 ASN LYS ASP GLY MET LEU VAL ALA TYR GLY ASN GLY PHE SEQRES 12 A 273 ILE THR ARG GLU PHE LEU LYS SER LEU ARG LYS PRO PHE SEQRES 13 A 273 CYS ASP ILE MET GLU PRO LYS PHE ASP PHE ALA MET LYS SEQRES 14 A 273 PHE ASN ALA LEU GLU LEU ASP ASP SER ASP ILE SER LEU SEQRES 15 A 273 PHE VAL ALA ALA ILE ILE CYS CYS GLY ASP ARG PRO GLY SEQRES 16 A 273 LEU LEU ASN VAL GLY HIS ILE GLU LYS MET GLN GLU GLY SEQRES 17 A 273 ILE VAL HIS VAL LEU ARG LEU HIS LEU GLN SER ASN HIS SEQRES 18 A 273 PRO ASP ASP ILE PHE LEU PHE PRO LYS LEU LEU GLN LYS SEQRES 19 A 273 MET ALA ASP LEU ARG GLN LEU VAL THR GLU HIS ALA GLN SEQRES 20 A 273 LEU VAL GLN ILE ILE LYS LYS THR GLU SER ASP ALA ALA SEQRES 21 A 273 LEU HIS PRO LEU LEU GLN GLU ILE TYR ARG ASP MET TYR SEQRES 1 B 15 LEU THR GLU ARG HIS LYS ILE LEU HIS ARG LEU LEU GLN SEQRES 2 B 15 GLU GLY SEQRES 1 C 273 GLY SER HIS MET THR ALA ASP LEU LYS SER LEU ALA LYS SEQRES 2 C 273 ARG ILE TYR GLU ALA TYR LEU LYS ASN PHE ASN MET ASN SEQRES 3 C 273 LYS VAL LYS ALA ARG VAL ILE LEU SER GLY LYS ALA SER SEQRES 4 C 273 ASN ASN PRO PRO PHE VAL ILE HIS ASP MET GLU THR LEU SEQRES 5 C 273 CYS MET ALA GLU LYS THR LEU VAL ALA LYS LEU VAL ALA SEQRES 6 C 273 ASN GLY ILE GLN ASN LYS GLU ALA GLU VAL ARG ILE PHE SEQRES 7 C 273 HIS CYS CYS GLN CYS THR SER VAL GLU THR VAL THR GLU SEQRES 8 C 273 LEU THR GLU PHE ALA LYS ALA ILE PRO GLY PHE ALA ASN SEQRES 9 C 273 LEU ASP LEU ASN ASP GLN VAL THR LEU LEU LYS TYR GLY SEQRES 10 C 273 VAL TYR GLU ALA ILE PHE ALA MET LEU SER SER VAL MET SEQRES 11 C 273 ASN LYS ASP GLY MET LEU VAL ALA TYR GLY ASN GLY PHE SEQRES 12 C 273 ILE THR ARG GLU PHE LEU LYS SER LEU ARG LYS PRO PHE SEQRES 13 C 273 CYS ASP ILE MET GLU PRO LYS PHE ASP PHE ALA MET LYS SEQRES 14 C 273 PHE ASN ALA LEU GLU LEU ASP ASP SER ASP ILE SER LEU SEQRES 15 C 273 PHE VAL ALA ALA ILE ILE CYS CYS GLY ASP ARG PRO GLY SEQRES 16 C 273 LEU LEU ASN VAL GLY HIS ILE GLU LYS MET GLN GLU GLY SEQRES 17 C 273 ILE VAL HIS VAL LEU ARG LEU HIS LEU GLN SER ASN HIS SEQRES 18 C 273 PRO ASP ASP ILE PHE LEU PHE PRO LYS LEU LEU GLN LYS SEQRES 19 C 273 MET ALA ASP LEU ARG GLN LEU VAL THR GLU HIS ALA GLN SEQRES 20 C 273 LEU VAL GLN ILE ILE LYS LYS THR GLU SER ASP ALA ALA SEQRES 21 C 273 LEU HIS PRO LEU LEU GLN GLU ILE TYR ARG ASP MET TYR HET BJB C 501 42 HETNAM BJB 4-[1-(1,3-BENZOTHIAZOL-6-YLSULFONYL)-5-CHLORO-INDOL-2- HETNAM 2 BJB YL]BUTANOIC ACID FORMUL 4 BJB C19 H15 CL N2 O4 S2 HELIX 1 AA1 ALA A 201 PHE A 218 1 18 HELIX 2 AA2 ASN A 221 LEU A 229 1 9 HELIX 3 AA3 ASP A 243 THR A 253 1 11 HELIX 4 AA4 GLU A 267 ALA A 293 1 27 HELIX 5 AA5 ASP A 301 SER A 322 1 22 HELIX 6 AA6 ARG A 341 LEU A 347 1 7 HELIX 7 AA7 PRO A 350 ASP A 353 5 4 HELIX 8 AA8 ILE A 354 LEU A 368 1 15 HELIX 9 AA9 ASP A 371 CYS A 384 1 14 HELIX 10 AB1 ASN A 393 HIS A 416 1 24 HELIX 11 AB2 PHE A 421 GLU A 451 1 31 HELIX 12 AB3 HIS A 457 ARG A 465 1 9 HELIX 13 AB4 LEU B 690 GLN B 695 1 6 HELIX 14 AB5 ALA C 201 LYS C 216 1 16 HELIX 15 AB6 ASN C 221 LEU C 229 1 9 HELIX 16 AB7 ASP C 243 LYS C 252 1 10 HELIX 17 AB8 GLU C 267 ILE C 294 1 28 HELIX 18 AB9 ASP C 301 SER C 322 1 22 HELIX 19 AC1 SER C 323 MET C 325 5 3 HELIX 20 AC2 ARG C 341 LYS C 345 1 5 HELIX 21 AC3 PHE C 351 LEU C 368 1 18 HELIX 22 AC4 ASP C 371 CYS C 384 1 14 HELIX 23 AC5 ASN C 393 HIS C 416 1 24 HELIX 24 AC6 PHE C 421 GLU C 451 1 31 HELIX 25 AC7 HIS C 457 ARG C 465 1 9 SHEET 1 AA1 4 PHE A 239 ILE A 241 0 SHEET 2 AA1 4 GLY A 337 THR A 340 1 O PHE A 338 N ILE A 241 SHEET 3 AA1 4 GLY A 329 VAL A 332 -1 N MET A 330 O ILE A 339 SHEET 4 AA1 4 MET A 325 ASN A 326 -1 N ASN A 326 O GLY A 329 SHEET 1 AA2 3 PHE C 239 ILE C 241 0 SHEET 2 AA2 3 GLY C 337 THR C 340 1 O THR C 340 N ILE C 241 SHEET 3 AA2 3 GLY C 329 VAL C 332 -1 N VAL C 332 O GLY C 337 CISPEP 1 ASN A 219 MET A 220 0 7.05 CISPEP 2 LYS A 349 PRO A 350 0 -1.16 CISPEP 3 ALA C 233 SER C 234 0 -0.74 CISPEP 4 LYS C 349 PRO C 350 0 1.08 CRYST1 59.733 101.383 60.361 90.00 98.48 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.016741 0.000000 0.002497 0.00000 SCALE2 0.000000 0.009864 0.000000 0.00000 SCALE3 0.000000 0.000000 0.016750 0.00000